Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: A trial of the Eastern Cooperative Oncology Group

Elizabeth Poplin*, Yang Feng, Jordan Berlin, Mace L. Rothenberg, Howard Hochster, Edith Mitchell, Steven Alberts, Peter O'Dwyer, Daniel Haller, Paul Catalano, David Cella, Al Bowen Benson

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

403 Scopus citations

Fingerprint

Dive into the research topics of 'Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: A trial of the Eastern Cooperative Oncology Group'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Nursing and Health Professions